EGFR Exon 20 Insertion Mutation

Medically Reviewed by Brunilda Nazario, MD on December 19, 2025

When you’re diagnosed with lung cancer, your doctor will classify it as one of two types: small cell lung cancer or non-small-cell lung cancer (NSCLC). NSCLC is far more common. About 85% of all lung cancers are NSCLC.

Within NSCLC, some tumors have genetic changes (mutations) that drive the cancer’s growth. One of these mutations affects a gene called epidermal growth factor receptor (EGFR). About 15%-20% of NSCLC cases have a mutation in the EGFR gene.

The EGFR gene is a template for a protein receptor on the surface of cells that helps a cell grow and divide. When the EGFR gene is normal, the EGFR receptor it creates turns the “grow and divide” process on and off according to your body’s needs. When the EGFR gene has a mutation, the EGFR that template creates may send “grow and divide” signals even when the body doesn’t need new cells. This makes cells grow and divide in an uncontrolled way, which forms a tumor.

EGFR mutations happen in different ways. Sometimes the EGFR gene has extra genetic material, sometimes one specific point of the genetic material mutates, and sometimes a piece of the gene is deleted. Exon 20 mutations are one type of EGFR mutation where extra genetic material is inserted into coding segment (exon) 20 of EGFR.

These insertions change the usual structure of EGFR proteins. This makes tumors with EGFR exon 20 insertions behave differently than more typical EGFR-mutant tumors. They can also respond differently to treatment.

photo of Who's On Your Care Team? infographic

What Are the Types of EGFR Exon 20 Insertion Mutation?

There are many ways EGFR 20 insertions can happen. Most involve the addition or copying of a small extra piece of genetic material. This usually means the EGFR protein has an extra 1 to 7 building blocks (amino acids).

These changes tend to happen most commonly in a specific part of the exon 20 section of the EGFR protein, in a small “loop” area just after a region scientists call the C-helix. There are less common exon 20 insertions that can also happen in earlier sections of the protein.

It’s important for your doctor to know the exact subtype of exon 20 insertion you have because it can affect the type of treatment you need. What works for one subtype may not work for another. The majority of exon 20 insertion mutations don’t respond well to the EGFR drugs that doctors prescribe for more typical EGFR mutations, such as exon 19 deletions or the exon 21 L858R mutation.

Some of the less common exon 20 insertions that happen in a section before the C-helix do respond to standard EGFR drugs. One example is an insertion that happens at section 763 of the EGFR protein.

What Are the Symptoms of an EGFR Exon 20 Insertion Mutation?

Symptoms of NSCLC with an EGFR exon 20 insertion mutation aren’t different from the symptoms you'd have with other forms of lung cancer. Often the symptoms you have depend on the stage of your cancer. In general, common symptoms of lung cancer include:

Chronic cough (especially if it’s a new cough or is getting worse over time)
Shortness of breath or breathlessness
Chest pain or discomfort
Coughing up blood
Unexplained weight loss
Loss of appetite
Fatigue, weakness, or less energy overall
Hoarseness
Repeated infections such as bronchitis or pneumonia

If your cancer has spread beyond your lungs, you may have other symptoms, such as:

Bone pain
Weakness or numbness in an arm or leg
Headaches, dizziness, or seizures
Balance problems or trouble walking
Yellow skin or eyes (jaundice)
Swollen lymph nodes in your neck or above your collarbone

Genetic testing can be key for identifying your specific subtype of lung cancer.

What Causes an EGFR Exon 20 Insertion Mutation?

Experts aren’t exactly sure why EGFR exon 20 insertion mutations happen in certain people. In general, cancer mutations can happen because of a combination of genetic history, random DNA errors, and environmental triggers.

But researchers have learned some patterns that can help identify some of the risk factors for having an EGFR mutation with exon 20 insertion.

People with this cancer subtype tend to be:

People who have never smoked
Women
People of Asian descent
People with a type of NSCLC called adenocarcinoma
Young adults with lung cancer

Finding Expert Care

If you or a loved one has been diagnosed with NSCLC, it’s helpful to seek care from a thoracic oncologist (lung‑cancer specialist) with experience treating cancer-driving mutations like EGFR. Typically you can find oncologists with this speciality at cancer centers or academic medical centers.

Genetic testing is a crucial part of getting proper treatment for your NSCLC. With a specialist who understands NSCLC, you will be more likely to have this testing and get the therapy you need.

Cancer centers with thoracic oncologists are also more likely to know more about the latest targeted therapies and clinical trials you may be eligible for.

Getting a Diagnosis

Getting a diagnosis of NSCLC with EGFR exon 20 insertion mutation involves several steps. Your initial lung cancer diagnosis will happen with imaging and biopsy. Then your doctor can narrow down the subtype of your cancer with biomarker tests.

Examples of these tests include:

Imaging. Your doctor will likely start with a test that takes a picture of the inside of your body. You may have an X-ray, CT scan, MRI, or PET scan.
Biopsy. If your images show abnormal spots, your doctor will want a biopsy to confirm the type of cancer you have. Your doctor will take either a sample of the tumor using a procedure called a bronchoscopy or a sample of the fluid in your lungs using a needle. A pathologist looks at the cells under a microscope.
Molecular (biomarker) testing. These are special tests your doctor can order on your biopsied cells to look more closely at DNA and identify mutations. Many experts recommend using next‑generation sequencing (NGS) rather than older PCR-based tests to find exon 20 insertion mutations.

Questions for Your Doctor

When you meet with your oncologist after your lung cancer diagnosis, here are some helpful questions to ask:

What is my lung cancer subtype?
Has my cancer spread to other parts of my body, such as my lymph nodes?
What is the stage of my cancer? What does this mean?
Have you done next-generation sequencing testing on my tumor?
If yes, what biomarkers does my tumor have?
What is the specific variant of my exon 20 insertion?
Which treatments work best on my cancer subtype?
What are the most common side effects and risks of those treatments, and how can I manage them?
What is the plan for monitoring my cancer over time?
If treatment stops working, what are the next steps? Are there second-line therapies?
How much experience do you have treating people with NSCLC with EGFR exon 20 insertion mutations?
Am I eligible for any clinical trials?

How Is an Exon 20 Insertion Mutation Treated?

Exon 20 insertions alter EGFR in a way that makes many standard EGFR drugs less effective at treating your cancer. Treating NSCLC with this mutation often means using specific targeted therapies alongside surgeries, radiation, and chemotherapy.

Medications

Researchers have recently developed medications that aren’t first-line treatments but are given as subsequent treatments to better target exon 20 insertions.

Amivantamab (Rybrevant). Amivantamab is a targeted therapy you get through an IV infusion. It works by attaching to both the EGFR protein and another protein called MET. This helps your immune system attack cancer cells and also block cancer growth signals. You might use it alone or your doctor may combine it with chemotherapy. In December 2025, the FDA approved Rybrevant Faspro as the first subcutaneous EGFR-targeted therapy for EGFR-mutated NSCLC. In February 2026, the FDA approved an every-four-weeks dosing schedule of Rybrevant Faspro.
Sunvozertinib (Zegfrovy). The FDA approved this pill in July 2025. Doctors typically prescribe sunvozertinib once you’ve tried chemotherapy and your cancer continues to progress. It’s in a class of drugs called tyrosine kinase inhibitors.
Chemotherapy. Doctors continue to prescribe chemotherapy you get through IV infusion, specifically platinum-based chemotherapy, as a standard treatment for NSCLC with EGFR exon 20 insertion mutation.

The type of exon 20 insertion you have will make a difference in which treatment approach your doctor recommends for you.

Surgery

You may be able to have surgery as part of your cancer treatment, especially if you’re in an early stage and your cancer hasn’t spread outside your lungs. The surgery your doctor may recommend is called a lobectomy.

During a lobectomy, your doctor removes a lobe or a section of a lobe of your lung. For some people, this can be a cure for their cancer. However, many exon 20 insertion tumor diagnoses happen after the cancer has spread, so targeted and systematic therapies are more common than surgery.

Natural or alternative treatments

Alternative therapies are herbal supplements, diets, vitamins or other alternative medicine that you use instead of doctor-prescribed medical treatments. There is no evidence that alternative therapies can treat or cure NSCLC with EGFR exon 20 insertion mutation. Because genetic mutation is the driver behind your cancer’s uncontrolled growth, the best treatment is medical intervention such as targeted therapy, chemotherapy, and surgery.

Your doctor may support the use of certain therapies as complementary medicine. This means you use them alongside your medical treatment to help you control pain, lessen side effects of cancer or cancer treatment and improve your quality of life. It’s important that you discuss any complementary therapy with your doctor before trying it.

What to Expect (How Your Condition May Change Over Time)

How your NSCLC with EGFR exon 20 insertion mutation progresses will depend on many factors, including the stage of your cancer, insertion subtype, your overall health, and the treatment you take.

In general, NSCLC with EGFR exon 20 insertion mutation at different stages can look like:

Discovered early, tumor localized: You have a higher chance that surgery (or surgery plus chemotherapy) could be a treatment option. This can mean long-term control, remission, or even a cure.
Discovered later and has spread beyond the lung: Usually this means you need systematic therapy such as chemotherapy alongside targeted therapy. With newer drugs this can mean tumor shrinkage, slowed disease progression, and an improved quality of life.

Over time, some cancers may develop a resistance to therapy, especially with targeted drugs, or the disease may progress even with treatment.

When treatment doesn’t work

If your treatment course stops working, doctors may:

Do another biopsy on your tumor to see whether it has developed a new mutation or way to resist the drugs you’re taking. This helps doctors choose your next treatments.
Switch to another targeted therapy, or to chemotherapy, or enroll in a clinical trial for newer drugs.
Provide palliative care, which is care focusing on symptom control, quality of life, and supportive care.

What Are the Complications of an EGFR Exon 20 Insertion Mutation?

The complications you may have as part of your cancer depend partly on how advanced the cancer was when diagnosed and partly on the treatments you use. Some of the complications include:

Tumor growth and spread (metastasis). Because exon 20 insertion mutation drives cell growth, your cancer may spread to your lymph nodes, bones, brain, liver, or other organs.
Respiratory problems. As your lung tumor grows or spreads, you may have a cough that gets worse over time, breathlessness, fluid buildup in your lungs, or difficulty breathing.
Treatment side effects. Targeted therapies and chemotherapy can cause side effects such as fatigue, nausea, skin problems (rash), diarrhea, and toxicity to organs like your liver.
Resistance development. Even if a therapy works initially, the cancer may evolve resistance, meaning it stops responding over time. This is common with targeted therapy.
Emotional and mental health toll. Dealing with lung cancer and its treatment decisions, uncertainty, and prognosis can lead to anxiety, depression, and stress.

Taking Care of Yourself

Living with NSCLC can be challenging. But these lifestyle choices can help boost your overall wellness and emotional care and support.

Eat a balanced diet rich in protein, fruits, and vegetables to support strength and your immune system.
Drink plenty of water.
Ask your doctor what kind of exercise you can do. Gentle exercise such as walking, stretching, or tai chi can help your mobility, improve energy, and reduce fatigue.
Protect your lung health by avoiding irritants.
Rest when you need it.
Make choices that prioritize lower stress.

Caring for your mental and emotional health

Allow yourself to acknowledge and process your emotions without judgment. All emotions are valid and normal.
Consider counseling or therapy with a psychologist, social worker, or counselor. If possible, look for a mental health professional who has experience helping people living with cancer or other life-limiting conditions.
Practice stress‑reducing techniques such as meditation, breathing exercises, gentle movement, journaling, hobbies, or anything that brings you a feeling of peace.
Stay connected with loved ones, support groups, or other communities important to you. Isolation can worsen emotional strain. Share your fears and hopes with others so you aren’t alone.
Take an active role in your care. Ask questions, stay informed, and advocate for yourself to gain a sense of empowerment.

Where to get support

There are several resources for people with lung cancer and their loved ones, including those with EGFR exon 20 mutations.

Exon 20 Group is a hub that connects people living with exon 20 insertion mutations to the latest research, free services, and clinical trials.
The American Lung Association provides educational resources, support lines, and referrals to care centers.
LUNGevity helps people diagnosed with lung cancer find community and learn about navigating treatment and other aspects of cancer care, with a special section for people living with EGFR mutated cancers.

Information for Caregivers

If you’re supporting someone living with this cancer, here are some suggestions for how to support your loved one:

Listen. Emotional support matters. Sometimes just being present, offering to drive to appointments, or sitting through scans can be a huge comfort.
Help organize medical info. Keep a binder or digital record of test results, treatment plans, side effects, appointments, and questions.
Encourage good self‑care. Remind your loved one about nutrition, rest, gentle exercise, and mental health support.
Be an extra set of ears. Go to medical appointments and take notes so they can be fully present with their doctor during the visit.
Research support resources. Help them find local support groups, patient advocacy organizations, or financial or logistical help.

Don’t forget to also take care of yourself. Caregiving can be emotionally and physically draining. Find your own community through caregiver support groups, rest, and ask for help or backup when you need it.

Takeaways

NSCLC with EGFR exon 20 insertion mutation is a less common but important subtype of lung cancer. New targeted therapies have improved treatment for this type of cancer. Molecular testing through next generation sequencing is key to getting a proper diagnosis and effective treatment.